Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Experienced Patients”

366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 366 results

Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Post-approval studies (Phase 4)Study completedNCT01423812
What this trial is testing

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Who this might be right for
HIV
Ruth M. Rothstein CORE Center 60
Not applicableStudy completedNCT00557570
What this trial is testing

Evaluation and Monitoring of Patients With HIV Infectionn

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 600
Post-approval studies (Phase 4)Study completedNCT01691794
What this trial is testing

Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients

Who this might be right for
HIV, Pediatric
Bristol-Myers Squibb 108
Not applicableStudy completedNCT00051805
What this trial is testing

Promoting Adherence to Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 119
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Large-scale testing (Phase 3)Study completedNCT00573001
What this trial is testing

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 120
Not applicableStudy completedNCT00870792
What this trial is testing

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

Who this might be right for
HIV InfectionHIV Infections
National Institute on Drug Abuse (NIDA) 156
Testing effectiveness (Phase 2)Study completedNCT00622206
What this trial is testing

Pharmacokinetics of Low Dose Ritonavir

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Post-approval studies (Phase 4)Study completedNCT05744063
What this trial is testing

A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients

Who this might be right for
Primary Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum 13
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Large-scale testing (Phase 3)Study completedNCT01567735
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 107
Not applicableLooking for participantsNCT06976918
What this trial is testing

Research Platform Myelofibrosis and Anemia

Who this might be right for
Primary MyelofibrosisSecondary MyelofibrosisPost-polycythemia Vera Myelofibrosis+4 more
iOMEDICO AG 200
Early research (Phase 1)Study completedNCT00842634
What this trial is testing

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Who this might be right for
HIVHIV Infections
University of Pennsylvania 12
Not applicableStudy completedNCT00386971
What this trial is testing

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

Who this might be right for
HyperlipidemiaHIV Infections
University of California, Davis 13
Testing effectiveness (Phase 2)Study completedNCT00089492
What this trial is testing

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 64
Early research (Phase 1)Study completedNCT01000818
What this trial is testing

Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

Who this might be right for
HIV-1 InfectionHIV Infections
Merck Sharp & Dohme LLC 18
Load More Results